Allergy Treatment Market

Description

The allergy treatment market is anticipated to grow from US$ 21.77 billion in 2024 to US$ 33.5 billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.8% during the period from 2031 to 2031. Increased research and development (R&D) efforts are expected to be a significant trend in this market.

Analysis of the Allergy Treatment Market

Increased R&D initiatives aimed at creating innovative allergy medications are likely to emerge as a prominent trend in the near future. Although there are numerous allergy medications available, many patients suffering from respiratory allergies and asthma still experience inadequate control or insufficient treatment through symptomatic therapies. For instance, certain respiratory allergies can lead to asthma development. Consequently, leading manufacturers are initiating clinical trial programs focused on allergies, such as HAL Allergy B.V.'s "Allergen Immunotherapies" for respiratory allergies. Thus, the rise in R&D activities is expected to lead to the creation of new anti-allergic medications, significantly contributing to market growth from 2021 to 2031.

Overview of the Allergy Treatment Market

As reported by the Asthma Allergy Clinic, new findings from the World Allergy Organization (WAO) indicate that 14% of individuals have asthma, while 20% suffer from allergic rhinitis (AR), which causes IgE-mediated inflammation of the nasal mucosa. Currently, approximately 20-30% of the population in India is affected by one or more allergic conditions, with this prevalence expected to increase in the coming years. Therefore, the growing incidence of allergies is likely to drive demand for anti-allergic medications over the next decade.

Strategic Insights

Drivers and Opportunities in the Allergy Treatment Market

Increasing Allergy Incidence Boosts Demand for Anti-Allergic Medications

According to a report from the American Academy of Pediatrics, Hay Fever (allergic rhinitis) is the most prevalent type of allergy, contributing to significant treatment costs. The direct and indirect expenses for allergy treatment exceed US$7 billion annually. Effective allergy treatment is based on medical history, allergy test results, and the severity of symptoms. Immunotherapy is a viable treatment option for certain allergy sufferers, with two common forms: allergy shots and sublingual immunotherapy (SLIT). Allergy shots involve administering increasing doses of allergens over time, helping individuals become progressively less sensitive to those allergens. These shots can be effective for people allergic to pollen, pets, dust, bees, and other stinging insects, as well as for asthma sufferers. Thus, the rising number of allergy cases is a major driver for the global allergy treatment market.

New Drug Approvals Present Attractive Market Opportunities

The approval of new drugs for allergy treatment offers lucrative opportunities within the allergy treatment market. In June 2020, Cadila Pharmaceuticals Limited launched "Bilastine Syrup (30ml)" and Bilastine Tablets of 20mg strength. Furthermore, in March 2022, Perrigo Company plc received final approval from the USFDA for the over-the-counter (OTC) use of "Nasonex(R) 24HR Allergy (mometasone furoate monohydrate 50mcg)", marking the company's first Rx-to-OTC switch for "Nasonex" to enter the OTC market.

Segmentation Analysis of the Allergy Treatment Market

The allergy treatment market analysis is derived from key segments based on type, cause, disorder type, category, and end user.

The market is segmented by allergy type into eye allergies, rhinitis, asthma, skin allergies, food allergies, and others, with the rhinitis segment holding the largest market share in 2023.
By treatment type, the market is divided into anti-allergy drugs and immunotherapies, with the anti-allergy drugs segment capturing the largest market share in 2023.

Geographical Analysis of the Allergy Treatment Market

The geographical scope of the Allergy Treatment market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America leads the market, with the US holding the largest share of the allergy treatment market. The presence of leading manufacturers in the region and their innovative anti-allergic drugs with effective pharmacological properties contribute to this dominance. The Asia Pacific region is expected to experience the highest CAGR in the coming years.

Scope of the Allergy Treatment Market Report

Recent Developments in the Allergy Treatment Market

The Allergy Treatment market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Notable developments in the Allergy Treatment market include:

In February 2024, Novartis announced the US Food and Drug Administration (USFDA) approval of "Xolair (omalizumab)", a newly launched product designed to reduce allergic reactions, including anaphylaxis due to accidental exposure to certain foods in adults and pediatric patients aged 1 year and older with IgE-mediated food allergies. (Source: Novartis, Company Website, February 2024)

Coverage and Deliverables of the Allergy Treatment Market Report

The report titled "Allergy Treatment Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

Allergy treatment market size and forecast at global, regional, and country levels for all key market segments included in the scope
Trends in the Allergy Treatment market along with market dynamics such as drivers, restraints, and key opportunities
In-depth PEST/Porter's Five Forces and SWOT analysis
Analysis of the Allergy Treatment market covering key trends, global and regional frameworks, major players, regulations, and recent market developments
Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments in the Allergy Treatment market
Detailed profiles of key companies

Product Code: TIPRE00004584

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Allergy Treatment Market and By Allergy Type
- 1.3.2 Allergy Treatment Market and By Treatment
- 1.3.3 Allergy Treatment Market and By Geography

2. Allergy Treatment Market and Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Allergy Treatment Marketand Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 APAC PEST Analysis
- 4.2.4 MEA PEST Analysis
- 4.2.5 SCAM PEST Analysis
4.3 Expert Opinion
4.4 List of Companies, by Region

5. Allergy Treatment Market and Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing Adoption of Immunotherapy in Allergy Treatment
- 5.1.2 Developments in Food Allergy Treatments
5.2 Key Market Restraints
- 5.2.1 Lack of Awareness About Allergy Treatments
5.3 Key Market Opportunities
- 5.3.1 Growing Number of Allergy-Related Research Projects and Programs
5.4 Future Trends
- 5.4.1 Development and Approvals of Innovative Medicines such as Biologics for Treating Allergies and Asthma
5.5 Impact Analysis

6. Allergy Treatment Market and Global Analysis

6.1 Global Allergy Treatment Marker Revenue Forecast and Analysis
6.2 Global Allergy Treatment Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Allergy Treatment Market Analysisand by Allergy Type

7.1 Overview
7.2 Allergy Treatment Market, by Allergy Type 2020 and 2031 (%)
7.1 Eye Allergy
- 7.1.1 Overview
- 7.1.2 Eye Allergy: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
7.2 Rhinitis
- 7.2.1 Overview
- 7.2.2 Rhinitis: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
7.3 Asthma
- 7.3.1 Overview
- 7.3.2 Asthma: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
7.4 Skin Allergy
- 7.4.1 Overview
- 7.4.2 Skin Allergy: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
7.5 Food Allergies
- 7.5.1 Overview
- 7.5.2 Food Allergies: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
7.6 Other Allergies
- 7.6.1 Overview
- 7.6.2 Other Allergies: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)

8. Allergy Treatment Market Analysisand by Treatment

8.1 Overview
8.2 Allergy Treatment Market, by Treatment 2020 and 2031 (%)
8.3 Anti-Allergy Drugs
- 8.3.1 Overview
- 8.3.2 Anti-Allergy Drugs: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
- 8.3.3 Antihistamines
  - 8.3.3.1 Overview
  - 8.3.3.2 Antihistamines: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
- 8.3.4 Corticosteroids
  - 8.3.4.1 Overview
  - 8.3.4.2 Corticosteroids: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
- 8.3.5 Decongestants
  - 8.3.5.1 Overview
  - 8.3.5.2 Decongestants: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
- 8.3.6 Other Drug
  - 8.3.6.1 Overview
  - 8.3.6.2 Other Drug: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
8.4 Immunotherapy
- 8.4.1 Overview
- 8.4.2 Immunotherapy: Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
- 8.4.3 Sub-cutaneous Immunotherapy (SCIT)
  - 8.4.3.1 Overview
  - 8.4.3.2 Sub-cutaneous Immunotherapy (SCIT): Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)
- 8.4.4 Sub-Lingual Immunotherapy (SLIT)
  - 8.4.4.1 Overview
  - 8.4.4.2 Sub-Lingual Immunotherapy (SLIT): Allergy Treatment Market and Revenue and Forecasts to 2031 (US$ Million)

9. Allergy Treatment Market and Geographical Analysis

9.1 North America: Allergy Treatment Market
- 9.1.1 Overview
- 9.1.2 North America: Allergy Treatment Market - Revenue and Forecasts to 2031 (USD Million)
- 9.1.3 North America: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
- 9.1.4 North America: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
  - 9.1.4.1 North America: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
  - 9.1.4.2 North America: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.1.5 North America: Allergy Treatment Market, by Country, 2020 and 2031 (%)
- 9.1.6 US: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.1.6.1 US: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.1.6.2 US: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.1.6.3 US: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.1.6.3.1 US: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.1.6.3.2 US: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.1.7 Canada: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.1.7.1 Canada: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.1.7.2 Canada: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.1.7.3 Canada: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.1.7.3.1 Canada: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.1.7.3.2 Canada: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.1.8 Mexico: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.1.8.1 Mexico: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.1.8.2 Mexico: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.1.8.3 Mexico: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.1.8.3.1 Mexico: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.1.8.3.2 Mexico: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
9.2 Europe: Allergy Treatment Market
- 9.2.1 Overview
- 9.2.2 Europe: Allergy Treatment Market - Revenue and Forecasts to 2031 (USD Million)
- 9.2.3 Europe: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
- 9.2.4 Europe: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
  - 9.2.4.1 Europe: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
  - 9.2.4.2 Europe: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.2.5 Europe: Allergy Treatment Market, by Country, 2020 and 2031 (%)
- 9.2.6 Germany: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.2.6.1 Germany: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.2.6.2 Germany: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.2.6.3 Germany: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.2.6.3.1 Germany: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.2.6.3.2 Germany: Allergy Treatment Market, by Immunotherapy 2024 and 2031 (USD Million)
- 9.2.7 UK: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.2.7.1 UK: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.2.7.2 UK: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.2.7.3 UK: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.2.7.3.1 UK: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.2.7.3.2 UK: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.2.8 France: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.2.8.1 France: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.2.8.2 France: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.2.8.3 France: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.2.8.3.1 France: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.2.8.3.2 France: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.2.9 Italy: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.2.9.1 Italy: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.2.9.2 Italy: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.2.9.3 Italy: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.2.9.3.1 Italy: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.2.9.3.2 Italy: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.2.10 Spain: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.2.10.1 Spain: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.2.10.2 Spain: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.2.10.3 Spain: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.2.10.3.1 Spain: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.2.10.3.2 Spain: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.2.11 Rest of Europe: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.2.11.1 Rest of Europe: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.2.11.2 Rest of Europe: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.2.11.3 Rest of Europe: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.2.11.3.1 Rest of Europe: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.2.11.3.2 Rest of Europe: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
9.3 Asia-Pacific: Allergy Treatment Market
- 9.3.1 Overview
- 9.3.2 Asia-Pacific: Allergy Treatment Market - Revenue and Forecasts to 2031 (USD Million)
- 9.3.3 Asia-Pacific: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
- 9.3.4 Asia-Pacific: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
  - 9.3.4.1 Asia-Pacific: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
  - 9.3.4.2 Asia-Pacific ca: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.3.5 Asia-Pacific: Allergy Treatment Market, by Country, 2020 and 2031 (%)
- 9.3.6 China: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.3.6.1 China: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.3.6.2 China: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.3.6.3 China: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.3.6.3.1 China: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.3.6.3.2 China: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.3.7 Japan: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.3.7.1 Japan: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.3.7.2 Japan: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.3.7.3 Japan: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.3.7.3.1 Japan: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.3.7.3.2 Japan: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.3.8 India: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.3.8.1 India: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.3.8.2 India: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.3.8.3 India: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.3.8.3.1 India: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.3.8.3.2 India: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.3.9 Australia: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.3.9.1 Australia: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.3.9.2 Australia: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.3.9.3 Australia: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.3.9.3.1 Australia: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.3.9.3.2 Australia: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.3.10 South Korea: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.3.10.1 South Korea: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.3.10.2 South Korea: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.3.10.3 South Korea: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.3.10.3.1 South Korea: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.3.10.3.2 South Korea: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.3.11 Rest of Asia-Pacific: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.3.11.1 Rest of Asia-Pacific: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.3.11.2 Rest of Asia-Pacific: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.3.11.3 Rest of Asia-Pacific: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.3.11.3.1 Rest of Asia-Pacific: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.3.11.3.2 Rest of Asia-Pacific: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
9.4 Middle East and Africa: Allergy Treatment Market
- 9.4.1 Overview
- 9.4.2 Middle East and Africa: Allergy Treatment Market - Revenue and Forecasts to 2031 (USD Million)
- 9.4.3 Middle East and Africa: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
- 9.4.4 Middle East and Africa: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
  - 9.4.4.1 Middle East and Africa: Allergy Treatment, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
  - 9.4.4.2 Middle East and Africa: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.4.5 Middle East and Africa: Allergy Treatment Market, by Country, 2020 and 2031 (%)
- 9.4.6 Saudi Arabia: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.4.6.1 Saudi Arabia: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.4.6.2 Saudi Arabia: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.4.6.3 Saudi Arabia: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.4.6.3.1 Saudi Arabia: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.4.6.3.2 Saudi Arabia: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.4.7 South Africa: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.4.7.1 South Africa: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.4.7.2 South Africa: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.4.7.3 South Africa: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.4.7.3.1 South Africa: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.4.7.3.2 South Africa: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.4.8 UAE: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.4.8.1 UAE: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.4.8.2 UAE: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.4.8.3 UAE: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.4.8.3.1 UAE: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.4.8.3.2 UAE: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
- 9.4.9 Rest of Middle East and Africa: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.4.9.1 Rest of Middle East and Africa: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.4.9.2 Rest of Middle East and Africa: Allergy Treatment Market, by Allergy Type, 2024 and 2031 (USD Million)
  - 9.4.9.3 Rest of Middle East and Africa: Allergy Treatment Market, by Treatment, 2024 and 2031 (USD Million)
    - 9.4.9.3.1 Rest of Middle East and Africa: Allergy Treatment Market, by Anti-Allergy Drugs, 2024 and 2031 (USD Million)
    - 9.4.9.3.2 Rest of Middle East and Africa: Allergy Treatment Market, by Immunotherapy, 2024 and 2031 (USD Million)
9.5 South and Central America: Allergy Treatment Market
- 9.5.1 Overview
- 9.5.2 South and Central America: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
- 9.5.3 South and Central America Allergy Treatment Market, by Allergy Type and Revenue and Forecasts to 2031 (USD Million)
- 9.5.4 South and Central America Allergy Treatment Market, by Treatmentand Revenue and Forecasts to 2031 (USD Million)
  - 9.5.4.1 South and Central America: Allergy Treatment Market, by Anti-Allergy Drugs and Revenue and Forecasts to 2031 (USD Million)
  - 9.5.4.2 South and Central America: Allergy Treatment Market, by Immunotherapy and Revenue and Forecasts to 2031 (USD Million)
  - 9.5.4.3 South and Central America: Allergy Treatment Market, by Country, 2020 and 2031 (%)
- 9.5.5 Brazil: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.5.5.1 Brazil: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.5.5.2 Brazil Allergy Treatment Market, by Allergy Type and Revenue and Forecasts to 2031 (USD Million)
  - 9.5.5.3 Brazil Allergy Treatment Market, by Treatmentand Revenue and Forecasts to 2031 (USD Million)
    - 9.5.5.3.1 Brazil: Allergy Treatment Market, by Anti-Allergy Drugs and Revenue and Forecasts to 2031 (USD Million)
    - 9.5.5.3.2 Brazil: Allergy Treatment Market, by Immunotherapy and Revenue and Forecasts to 2031 (USD Million)
- 9.5.6 Argentina: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.5.6.1 Argentina: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.5.6.2 Argentina Allergy Treatment Market, by Allergy Type and Revenue and Forecasts to 2031 (USD Million)
  - 9.5.6.3 Argentina Allergy Treatment Market, by Treatmentand Revenue and Forecasts to 2031 (USD Million)
  - 9.5.6.4 Argentina: Allergy Treatment Market, by Anti-Allergy Drugs and Revenue and Forecasts to 2031 (USD Million)
  - 9.5.6.5 Argentina: Allergy Treatment Market, by Immunotherapy and Revenue and Forecasts to 2031 (USD Million)
- 9.5.7 Rest of South and Central America: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.5.7.1 Rest of South and Central America: Allergy Treatment Market and Revenue and Forecasts to 2031 (USD Million)
  - 9.5.7.2 Rest of South and Central America Allergy Treatment Market, by Allergy Type and Revenue and Forecasts to 2031 (USD Million)
  - 9.5.7.3 Rest of South and Central America Allergy Treatment Market, by Treatmentand Revenue and Forecasts to 2031 (USD Million)
    - 9.5.7.3.1 Rest of South and Central America: Allergy Treatment Market, by Anti-Allergy Drugs and Revenue and Forecasts to 2031 (USD Million)
    - 9.5.7.3.2 Rest of South and Central America: Allergy Treatment Market, by Immunotherapy and Revenue and Forecasts to 2031 (USD Million)

10. Impact of COVID-19 Pandemic on Global Allergy Treatment Market

10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Allergy Treatment Marketand Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 Johnson and Johnson Services, Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Sanofi
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 AbbVie Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Pfizer Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 LETI Pharma
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 ALK-Abello A/S
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Allergy Therapeutics
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Stallergenes Greer
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 GlaxoSmithKline plc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Dermapharm Holding
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About the Insight Partners
13.2 Glossary of Terms

14. Appendix

14.1 About the Insight Partners
14.2 Glossary of Terms